Nevertheless, a recent meta-analysis encompassing up to 76 randomized controlled trials concluded that GLP-1 RA treatment was associated with a significant, albeit low, increased risk of gallbladder or biliary diseases (relative risk (RR), 1.37
In the Retatrutide trial, it was noted: this is an unusually high magnitude of efficacy as compared with findings in clinical trials of other anti- obesity agents, although it has been observed with bariatricmetabolic surgery . Basically, if we could give everyone in America bariatric surgery, we could probably solve the obesity epidemic
As your weight loss progresses and abdominal fat decreases, you may need to transition to other sites or adjust your technique to maintain proper subcutaneous delivery
These drugs are emulating a protein molecule we have in our body, so if youre putting something in there that is low quality, the risk is that you get antibodies, that you have an autoimmune reaction to that chemical, says Angela Fitch, MD, chief medical officer at Knownwell
Furthermore, GLP-1 decreases gastrointestinal motility extending the entry of nutrients to be absorbed by the GIT [18]
Are GLP-1 Medications Safe
